Post-Traumatic Stress Disorder (PTSD): Symptoms, Diagnosis, Treatment & Red Flags

PTSD belongs to the DSM-5-TR trauma- and stressor-related disorders family. It encodes a persistent maladaptive stress response after catastrophic or violent experiences: threat-processing networks (amygdala-forward) remain tonically engaged while prefrontal regulatory capacity fails to re-label the event as time-limited. The result is re-experiencing phenomena, defensive avoidance, negative self/world attributions, and somatic arousal that patients often describe as “stuck on high alert.” Functional imaging and psychophysiology studies show exaggerated cue reactivity and deficient extinction learning compared with resilient trauma survivors; clinically, that maps to patients who rehearse trauma in sleep, scan environments for danger, and withdraw from reminders—including care that unconsciously resembles prior institutional betrayal.

Most exposed individuals never meet PTSD criteria; development depends on trauma dose, peri-traumatic dissociation, prior adversity, social support, and concurrent depression or substance use. Because PTSD elevates medical utilisation, occupational disability, and suicide risk, early structured assessment—rather than watchful neglect—matches the burden described in national guidance from NICE NG116 and the VA/DoD clinical practice guideline.

Clinicians anchor charting to four DSM-5-TR clusters (minimum symptom counts per cluster apply). Dissociative specifier merits documentation when depersonalisation or derealisation dominates—delivery systems may track different therapy pacing. Delayed expression beyond six months is recognised; childhood abuse or repeated occupational trauma may present only when a new stressor exceeds coping reserves.

↔On a small screen, swipe or scroll sideways to see the full table.

Ward teams may see cardiovascular over-reactivity, non-epileptic spell-like presentations, somatic pain, or “anger out of proportion.” Military and first-responder cohorts report emotional numbing masquerading as professionalism. Refugees and racialised minorities may present somatically due to stigma—interpreter-led, trauma-informed interviews reduce re-traumatisation. Peripartum individuals can manifest hyperstartle, poor bonding guilt, and insomnia that midwives mislabel as routine fatigue.

Atypical or easily misread faces

• Dissociative blankness interpreted as indifference or low engagement with therapy.
• Panic disorder–like surges without clear cognition—still map triggers to trauma cueing.
• Chronic pain, pelvic pain, or functional neurological symptoms as primary complaint.
• Coercive-control trauma where patient minimises danger—collateral risk assessment when safe and consented.

PTSD is not weakness; it reflects interaction between event severity, developmental timing, genetics affecting HPA axis responsivity, and social buffers. Interpersonal violence, sexual assault, sudden violent loss, childhood maltreatment, and prolonged occupational hazard exposure carry higher conditional risk than single benign accidents. Institutional betrayal (clergy, military, healthcare) worsens moral injury themes. Protective factors include early psychoeducation, perceived control, credible social support, and timely evidence-based therapy. Non-modifiable markers (prior anxiety disorders, family mood history) indicate closer monitoring after trauma exposure.

Clinical assessment

Establish Criterion A stressor with timeline, dissociation peri-trauma, and functional impact across relationships and work. Screen for comorbid depression, anxiety, and bipolar spectrum—SSRIs without mood stabiliser vigilance can be hazardous if bipolarity emerges. Use structured tools where services support it: PCL-5 self-report for repeat measurement; CAPS-5 when diagnosticians trained.

Laboratory investigations

No blood test diagnoses PTSD; targeted tests rule out mimics—thyroid function when hyperarousal is unexplained, metabolic panels when alcohol dependence suspected, and urine drug screens when misuse could drive presentation or contraindicate medication choices.

Imaging

Not first-line. Consider neurology imaging only for focal deficits or atypical features suggesting structural disease.

Diagnostic criteria and scoring systems

DSM-5-TR supplies the prevailing research and US regulatory framework; ICD-11’s complex PTSD construct (affect dysregulation, negative self-concept, interpersonal disturbance) overlaps partially—document symptom domains if your jurisdiction uses ICD-11 coding bundles.

↔On a small screen, swipe or scroll sideways to see the full table.

First-line psychological treatment

Trauma-focused cognitive behavioural therapies—prolonged exposure (PE), cognitive processing therapy (CPT), narrative exposure—and trauma-focused CBT for younger patients yield the strongest randomised evidence. EMDR remains guideline-supported where trained therapists exist. Skills stabilisation may precede imaginal exposure when dissociation or emotion dysregulation is severe.

Pharmacotherapy

Adult sertraline and paroxetine carry US FDA PTSD indications; fluoxetine is used off-label internationally. Venlafaxine offers SNRI alternative—watch hypertension. Mirtazapine sometimes aids comorbid insomnia or poor appetite under specialist guidance. Prazosin may reduce nightmare burden in selected adults—monitor orthostasis. Benzodiazepines are not first-line monotherapy per multiple guidelines because of limited PTSD-specific benefit and dependence risk.

Special populations & emerging options

Pregnancy and breastfeeding decisions require MDT risk–benefit dialogue. Older adults need falls and hyponatraemia surveillance. Intravenous ketamine and MDMA-assisted therapy remain trial- or programme-specific—document enrolment criteria and never equate with ward-standard care.

• Monitoring cadence: Nursing reviews 1–2 weeks after SSRI/SNRI initiation or dose change; sooner if prior suicidality, youth, or recent discharge.
• Treatment failure signals: Lack of ≥20–30% symptom change on validated scale after adequate psychotherapy dose (roughly 8–12 sessions) or medication trial (≥8 weeks at therapeutic dose)—refer for specialist stratification.
• Drug interactions: Serotonergic combinations raise serotonin syndrome risk; NSAID plus SSRI increases bleed risk—coach proton-pump protection when indicated.
• Adherence: Link pill-taking to daily anchor; address avoidance of pharmacy or clinic buildings resembling trauma sites (telehealth, outreach).
• Referral thresholds: Complex developmental trauma, dissociative disorder comorbidity, or treatment-resistant cases merit psychology/psychiatry MDT and sometimes intensive outpatient programmes.

Chronic PTSD amplifies cardiometabolic risk through chronic stress physiology, sleep fragmentation, and tobacco use. Relationship breakdown, occupational loss, and medical comorbidity stack over years. Suicide risk peaks around trauma anniversaries and after sudden loss of perceived safety—maintain proactive contact. Chronic pain and functional syndromes often co-travel, requiring coordinated rehabilitation rather than siloed dismissal.

Universal debriefing immediately after trauma is not evidence-supported and may harm some individuals. Better targets: screen high-risk cohorts, deliver psychoeducation that normalises stress responses, embed Psychological First Aid principles, and fast-track evidence-based therapy referral in symptomatic subgroups. Occupational health programmes for first responders should pair mental health literacy with protected time for treatment.

With trauma-focused therapy and/or appropriate pharmacotherapy, many patients achieve meaningful symptom reduction within months; a subset develops chronic fluctuating illness needing episodic booster therapy. Prognosis worsens with ongoing threat (e.g., unrepaired domestic violence), untreated substance use, or pervasive social isolation. Honest framing—“symptoms may spike under new stress”—reduces shame and promotes return to care.

Signal instead of noise

Track micro-shifts: escalating night sweats, increased substance use concealment, casual remarks about “not being here next month,” or sudden brightening after intent formation (relief). Compare collateral accounts when safe—traumatised patients may minimise danger.

Environment & communication

Offer choice where possible (door ajar, gender-matched staff if requested), announce touch before vitals, and avoid pressure to disclose trauma narrative in corridors. Pair medication reconciliation with plain-language explanations of why SSRIs take weeks.

Bedside documentation checklist

• Triggers observed, interventions that calmed versus escalated.
• Suicide protective factors (connection to children, future goals) alongside risk factors.
• Substance use pattern if relevant; withdrawal red flags.
• Follow-up who/when/where written in patient-owned language.

First actions: private safety assessment, remove or secure means when lawful, involve crisis team or emergency services per protocol, communicate trauma history without sensational detail, and ensure warm handoff with written risk formulation.

These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching, and cloze completion on the topic of PTSD assessment, trauma-informed safety, guideline-consistent therapy, and medication stewardship—aligned with Clinical Judgment Measurement Model reasoning from cue recognition through evaluation of outcomes.